Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Respiratory Medicine
|
July 10, 2024
Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus
Jacqueline Brewer, Melisa Wilson, James C Coons, et al.
Pulmonary Circulation
|
May 4, 2022
An expert panel Delphi consensus statement on the use of palliative care in the management of patients with pulmonary arterial hypertension
Melisa Wilson, Rebekah H Anguiano, Rana L A Awdish, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
|
April 17, 2025
A Platform Designed to Empower Quality Improvement for Patients with Atrial Fibrillation
Thomas F Deering, Anne Marie Smith, John A Gillespie, et al.
The European Respiratory Journal
|
August 7, 2025
Pericardial Effusions And Sotatercept Therapy in Pulmonary Arterial Hypertension: A Multicenter Real-World Experience
Sandeep Sahay, Nelson Villasmil Hernandez, Yassmin Al Aaraj, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.
Clinical Pharmacology and Therapeutics
|
September 8, 2020
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Craig R Lee, Cameron D Thomas, Amber L Beitelshees, et al.
Journal of the American Heart Association
|
February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
Amber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
Clinical Pharmacology and Therapeutics
|
December 28, 2017
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy
Philip E Empey, James M Stevenson, Sony Tuteja, et al.
JACC. Cardiovascular Interventions
|
November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Larisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Respiratory Medicine
|
July 10, 2024
Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus
Jacqueline Brewer, Melisa Wilson, James C Coons, et al.
Pulmonary Circulation
|
May 4, 2022
An expert panel Delphi consensus statement on the use of palliative care in the management of patients with pulmonary arterial hypertension
Melisa Wilson, Rebekah H Anguiano, Rana L A Awdish, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
|
April 17, 2025
A Platform Designed to Empower Quality Improvement for Patients with Atrial Fibrillation
Thomas F Deering, Anne Marie Smith, John A Gillespie, et al.
The European Respiratory Journal
|
August 7, 2025
Pericardial Effusions And Sotatercept Therapy in Pulmonary Arterial Hypertension: A Multicenter Real-World Experience
Sandeep Sahay, Nelson Villasmil Hernandez, Yassmin Al Aaraj, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.
Clinical Pharmacology and Therapeutics
|
September 8, 2020
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Craig R Lee, Cameron D Thomas, Amber L Beitelshees, et al.
Journal of the American Heart Association
|
February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
Amber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
Clinical Pharmacology and Therapeutics
|
December 28, 2017
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy
Philip E Empey, James M Stevenson, Sony Tuteja, et al.
JACC. Cardiovascular Interventions
|
November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Larisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Page
of 8